Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Trimetazidine-d9 (dihydrochloride)

Trimetazidine-d9 (dihydrochloride) is deuterium labeled Trimetazidine (dihydrochloride) . Trimetazidine dihydrochloride is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM, which can inhibit β-oxidation of free fatty acid (FFA) . Trimetazidine dihydrochloride is an effective antianginal agent and a cytoprotective agent, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties. Trimetazidine dihydrochloride triggers autophagy. Trimetazidine dihydrochloride is also a 3-hydroxyacyl-CoA dehydrogenase (HADHA) inhibitor[1][2][3][4][5].

Product Specifications

UNSPSC

12352005

Target

Autophagy; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Autophagy; Others

Field of Research

Cardiovascular Disease

Smiles

[2H]C([2H])([2H])OC1=CC=C(C(OC([2H])([2H])[2H])=C1OC([2H])([2H])[2H])CN2CCNCC2.Cl.Cl

Molecular Formula

C14H15D9Cl2N2O3

Molecular Weight

348.31

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Hossain F, et al.Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Cancer Immunol Res. 2015 Nov;3 (11) :1236-47.|[3]Kantor PF, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000 Mar 17;86 (5) :580-8.|[4]Shenghu He, et al. Protective effects of trimetazidine against vascular endothelial cell injury induced by oxidation. Journal of Geriatric Cardiology, December 2008 , Vol 5 No 4.|[5]Chrusciel P, et al. Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease. Drugs. 2014 Jun;74 (9) :971-80.|[6]Jain S, et al. Trimetazidine exerts protection against increasing current electroshock seizure test in mice. Seizure. 2010 Jun;19 (5) :300-2.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

RN5S183 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
LV743883 1.0 µg DNA

RN5S183 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

Sign In for Pricing
View Details
OR6B2, CT (OR6B2, OR6B2P, Olfactory receptor 6B2, Olfactory receptor OR2-1) (PE) discontinued
039465-PE 200 µL

OR6B2, CT (OR6B2, OR6B2P, Olfactory receptor 6B2, Olfactory receptor OR2-1) (PE) discontinued

Sign In for Pricing
View Details
Recombinant Viola arvensis Varv peptide C
MBS1023666-01 0.05 mg (E-Coli)

Recombinant Viola arvensis Varv peptide C

Sign In for Pricing
View Details
Recombinant Viola arvensis Varv peptide C
MBS1023666-02 0.2 mg (E-Coli)

Recombinant Viola arvensis Varv peptide C

Sign In for Pricing
View Details
Recombinant Viola arvensis Varv peptide C
MBS1023666-03 0.05 mg (Yeast)

Recombinant Viola arvensis Varv peptide C

Sign In for Pricing
View Details
Recombinant Viola arvensis Varv peptide C
MBS1023666-04 0.5 mg (E-Coli)

Recombinant Viola arvensis Varv peptide C

Sign In for Pricing
View Details